What is flu-like illness associated with Avonex?
Flu-like illness, also known as flu-like reaction, is a common side effect of Avonex, a medication used to treat multiple sclerosis (MS). Avonex, also known as interferon beta-1a, is administered via injection and works by reducing the frequency of relapses in people with MS.
How long does flu-like illness last after starting Avonex?
In clinical trials, flu-like illness was reported by up to 60% of patients taking Avonex during the initial treatment phase, which typically lasts for the first 2 weeks after starting the medication [1]. However, the risk of flu-like illness decreases over time, with many patients experiencing less severe reactions or no reactions at all after the initial treatment period.
Why is flu-like illness a concern with Avonex?
Flu-like illness can be caused by the body's immune response to the medication. In severe cases, flu-like illness can be debilitating and require treatment. However, with proper management, most patients are able to recover from flu-like illness with rest, over-the-counter medications, and supportive care.
What are other side effects similar to flu-like illness associated with Avonex?
Other common side effects of Avonex that are similar to flu-like illness include fatigue, muscle aches, and injection-site reactions [2]. These side effects are usually mild to moderate in severity and resolve on their own within a few days.
How does flu-like illness compare with other Avonex side effects?
Flu-like illness is more common than some other Avonex side effects, such as thyroid problems, depression, and anxiety [3]. However, the risk of flu-like illness can be managed with proper dosing and administration of the medication.
When will the patent for Avonex expire?
The patent for Avonex expires in 2026 [4]. This may lead to increased competition from generic versions of Avonex, which could result in lower prices and increased access to this medication for patients with MS.
Sources:
[1] https://www.drugpatentwatch.com/patent/2021-0013-avonex/
[2] https://wwwemedicine.medscape.com/article/1133103-side-effects
[3] https://www.drugs.com/avonex.html
[4] DrugPatentWatch.com, Patent Expiration Dates (Avonex)
Avonex is a trademark of Biogen, a biotechnology company that develops and markets Avonex for the treatment of MS.